Wendy Naimark
Fondateur chez Ripple Therapeutics Corp.
Profil
Wendy Naimark is the founder of Ripple Therapeutics Corp.
She is currently the Director at Ontario Bioscience Industry Organization since 2022.
Previously, she worked as the Senior Director-Clinical and Preclinical Sciences at Lyra Therapeutics, Inc. and as a Senior Manager at Boston Scientific Corp.
Dr. Naimark holds a graduate and doctorate degree from the University of Toronto.
Postes actifs de Wendy Naimark
| Sociétés | Poste | Début |
|---|---|---|
Ontario Bioscience Industry Organization
 Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services The Ontario Bioscience Industry Organization is a membership organization that engages in strategy, programming, policy development, and advocacy. The non-profit company is based in Toronto, Canada. The Canadian company was founded by Simon Goulet. Maura Campbell has been the CEO of the company since 2021. | Directeur/Membre du Conseil | 01/12/2022 |
| Ripple Therapeutics Corp. | Fondateur | - |
Anciens postes connus de Wendy Naimark
| Sociétés | Poste | Fin |
|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | Corporate Officer/Principal | - |
| LYRA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Wendy Naimark
| University of Toronto | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| LYRA THERAPEUTICS, INC. | Health Technology |
| BOSTON SCIENTIFIC CORPORATION | Health Technology |
| Entreprise privées | 2 |
|---|---|
Ontario Bioscience Industry Organization
Ontario Bioscience Industry Organization Miscellaneous Commercial ServicesCommercial Services The Ontario Bioscience Industry Organization is a membership organization that engages in strategy, programming, policy development, and advocacy. The non-profit company is based in Toronto, Canada. The Canadian company was founded by Simon Goulet. Maura Campbell has been the CEO of the company since 2021. | Commercial Services |
| Ripple Therapeutics Corp. |